Annual Shareholders Equity
-$10.66 M
-$33.04 M-147.62%
December 31, 2022
Summary
- As of February 26, 2025, ELOX annual stockholders equity is -$10.66 million, with the most recent change of -$33.04 million (-147.62%) on December 31, 2022.
- During the last 3 years, ELOX annual shareholders equity has fallen by -$46.87 million (-129.44%).
- ELOX annual shareholders equity is now -124.84% below its all-time high of $42.91 million, reached on December 31, 2018.
Performance
ELOX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$20.05 M
-$1.45 M-7.81%
September 30, 2023
Summary
- As of February 26, 2025, ELOX quarterly stockholders equity is -$20.05 million, with the most recent change of -$1.45 million (-7.81%) on September 30, 2023.
- Over the past year, ELOX quarterly shareholders equity has dropped by -$15.07 million (-302.41%).
- ELOX quarterly shareholders equity is now -133.46% below its all-time high of $59.92 million, reached on June 30, 2018.
Performance
ELOX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ELOX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -147.6% | -302.4% |
| 3 y3 years | -129.4% | -233.0% |
| 5 y5 years | -149.9% | -146.7% |
ELOX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -147.6% | at low | -189.6% | at low |
| 5 y | 5-year | -129.4% | at low | -149.3% | at low |
| alltime | all time | -124.8% | at low | -133.5% | at low |
Eloxx Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -$20.05 M(+7.8%) |
| Jun 2023 | - | -$18.60 M(+14.1%) |
| Mar 2023 | - | -$16.29 M(+52.8%) |
| Dec 2022 | -$10.66 M(-147.6%) | -$10.66 M(+114.0%) |
| Sep 2022 | - | -$4.98 M(-374.9%) |
| Jun 2022 | - | $1.81 M(-84.5%) |
| Mar 2022 | - | $11.69 M(-47.8%) |
| Dec 2021 | $22.38 M(+118.8%) | $22.38 M(-32.2%) |
| Sep 2021 | - | $33.00 M(-18.8%) |
| Jun 2021 | - | $40.64 M(+1377.9%) |
| Mar 2021 | - | $2.75 M(-73.1%) |
| Dec 2020 | $10.23 M(-71.8%) | $10.23 M(-32.2%) |
| Sep 2020 | - | $15.08 M(-25.7%) |
| Jun 2020 | - | $20.29 M(-22.7%) |
| Mar 2020 | - | $26.26 M(-27.5%) |
| Dec 2019 | $36.21 M(-15.6%) | $36.21 M(-19.9%) |
| Sep 2019 | - | $45.23 M(-18.1%) |
| Jun 2019 | - | $55.22 M(+60.4%) |
| Mar 2019 | - | $34.43 M(-19.8%) |
| Dec 2018 | $42.91 M(+100.9%) | $42.91 M(-16.6%) |
| Sep 2018 | - | $51.46 M(-14.1%) |
| Jun 2018 | - | $59.92 M(+343.7%) |
| Mar 2018 | - | $13.50 M(+307.4%) |
| Dec 2017 | $21.36 M(+2351.9%) | - |
| Sep 2017 | - | $3.31 M(+280.5%) |
| Jun 2017 | - | $871.20 K(-66.3%) |
| Jun 2017 | $871.20 K(-80.9%) | - |
| Mar 2017 | - | $2.58 M(-9.1%) |
| Dec 2016 | - | $2.84 M(-21.6%) |
| Sep 2016 | - | $3.63 M(-20.5%) |
| Jun 2016 | $4.56 M(-62.7%) | $4.56 M(-19.2%) |
| Mar 2016 | - | $5.64 M(-35.3%) |
| Dec 2015 | - | $8.72 M(-30.2%) |
| Sep 2015 | - | $12.51 M(+2.3%) |
| Jun 2015 | $12.22 M(-55.5%) | $12.22 M(+9.1%) |
| Mar 2015 | - | $11.21 M(-6.1%) |
| Dec 2014 | - | $11.94 M(-46.8%) |
| Sep 2014 | - | $22.43 M(-18.4%) |
| Jun 2014 | $27.49 M(+626.1%) | $27.49 M(+180.4%) |
| Mar 2014 | - | $9.80 M(+27.0%) |
| Dec 2013 | - | $7.72 M(+264.6%) |
| Sep 2013 | - | $2.12 M(-44.1%) |
| Jun 2013 | $3.79 M(+9.6%) | $3.79 M(+14.3%) |
| Mar 2013 | - | $3.31 M(+109.5%) |
| Dec 2012 | - | $1.58 M(-39.9%) |
| Sep 2012 | - | $2.63 M(-23.9%) |
| Jun 2012 | $3.45 M(-23.6%) | $3.45 M(-24.9%) |
| Mar 2012 | - | $4.60 M(+62.3%) |
| Dec 2011 | - | $2.83 M(-28.0%) |
| Sep 2011 | - | $3.93 M(-12.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2011 | $4.52 M(-43.4%) | $4.52 M(-34.5%) |
| Mar 2011 | - | $6.90 M(+2.7%) |
| Dec 2010 | - | $6.72 M(-6.8%) |
| Sep 2010 | - | $7.21 M(-9.7%) |
| Jun 2010 | $7.98 M(+40.8%) | $7.98 M(+4297.2%) |
| Mar 2010 | - | $181.50 K(-95.7%) |
| Dec 2009 | - | $4.22 M(-10.3%) |
| Sep 2009 | - | $4.70 M(-17.1%) |
| Jun 2009 | $5.67 M(-42.4%) | $5.67 M(-17.3%) |
| Mar 2009 | - | $6.86 M(-12.3%) |
| Dec 2008 | - | $7.82 M(-13.1%) |
| Sep 2008 | - | $8.99 M(-8.5%) |
| Jun 2008 | $9.84 M(+265.7%) | $9.84 M(+45.5%) |
| Mar 2008 | - | $6.76 M(-15.9%) |
| Dec 2007 | - | $8.04 M(+108.5%) |
| Sep 2007 | - | $3.86 M(+43.4%) |
| Jun 2007 | $2.69 M(-8.9%) | $2.69 M(-19.5%) |
| Mar 2007 | - | $3.34 M(-18.1%) |
| Dec 2006 | - | $4.08 M(+67.4%) |
| Sep 2006 | - | $2.44 M(-17.4%) |
| Jun 2006 | $2.95 M(-47.2%) | $2.95 M(-19.1%) |
| Mar 2006 | - | $3.65 M(-14.4%) |
| Dec 2005 | - | $4.26 M(-13.6%) |
| Sep 2005 | - | $4.93 M(-11.7%) |
| Jun 2005 | $5.59 M(+18.2%) | $5.59 M(+71.5%) |
| Mar 2005 | - | $3.26 M(-15.7%) |
| Dec 2004 | - | $3.87 M(-7.5%) |
| Sep 2004 | - | $4.18 M(-11.6%) |
| Jun 2004 | $4.73 M(+65.6%) | $4.73 M(-2.2%) |
| Mar 2004 | - | $4.84 M(+149.3%) |
| Dec 2003 | - | $1.94 M(-15.6%) |
| Sep 2003 | - | $2.30 M(-19.5%) |
| Jun 2003 | $2.86 M(-40.3%) | $2.86 M(-14.2%) |
| Mar 2003 | - | $3.33 M(-13.4%) |
| Dec 2002 | - | $3.85 M(-10.8%) |
| Sep 2002 | - | $4.31 M(-9.9%) |
| Jun 2002 | $4.79 M(-2415.3%) | $4.79 M(+34.8%) |
| Mar 2002 | - | $3.55 M(+34.2%) |
| Dec 2001 | - | $2.64 M(-577.2%) |
| Sep 2001 | - | -$554.10 K(+168.1%) |
| Jun 2001 | -$206.70 K(-113.6%) | -$206.70 K(-199.5%) |
| Mar 2001 | - | $207.70 K(-66.3%) |
| Dec 2000 | - | $616.20 K(-43.1%) |
| Sep 2000 | - | $1.08 M(-28.7%) |
| Jun 2000 | $1.52 M(+66.5%) | $1.52 M(+8383.8%) |
| Mar 2000 | - | $17.90 K(-82.1%) |
| Dec 1999 | - | $100.00 K |
| Jun 1999 | $912.20 K(<-9900.0%) | - |
| Jun 1998 | -$3100.00(-11.4%) | - |
| Jun 1997 | -$3500.00 | - |
FAQ
- What is Eloxx Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals annual shareholders equity year-on-year change?
- What is Eloxx Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Eloxx Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of ELOX is -$10.66 M
What is the all time high annual shareholders equity for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high annual stockholders equity is $42.91 M
What is Eloxx Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, ELOX annual stockholders equity has changed by -$33.04 M (-147.62%)
What is Eloxx Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of ELOX is -$20.05 M
What is the all time high quarterly shareholders equity for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high quarterly stockholders equity is $59.92 M
What is Eloxx Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, ELOX quarterly stockholders equity has changed by -$15.07 M (-302.41%)